Literature DB >> 19676012

[Medical radiation exposure and justification at a large teaching hospital: comparison of radiation-related and disease-related risks].

R W Loose1, U Popp, M Wucherer, R Adamus.   

Abstract

PURPOSE: The medical X-ray exposure was determined in a 2400-bed hospital. The radiation-related risk was compared with the severity of disease (ICD) to verify the justification for X-ray procedures. A model to estimate radiation and disease-related "loss of lifetime" was applied.
MATERIALS AND METHODS: X-ray exposure from radiography, fluoroscopy and CT was determined for diagnostic and interventional procedures during one hospital stay of 403 patients (0.5 % of all 80 000 patients/year). CTDI and DLP in CT, DAP in fluoroscopy or SED in radiography were used to calculate the effective dose (ED). The disease and radiation-related risk were compared with a simple "loss of lifetime" model.
RESULTS: The mean age of all patients was 60. Only a subgroup of 170 patients (42 %) with a mean age of 67.6 had one or more X-ray procedures. The average ED of these exposed patients was 5.12 mSv. 14.4 % CT examinations had a dose contribution of 52.5 % followed by 5.3 % radiology and cardiology procedures at 37.2 %. 90 % of ED was applied to only 44 patients (11 %) and 50 % of ED was applied to only 10 patients (2.5 %) with a mean age of 71.2. 4 of these 10 patients had malignant tumors, the other 6 suffered from pulmonary embolism, pneumonia, stent-graft infection, CAD, Crohn's disease and severe hypertension. The ratio of disease vs. radiation-related risk was between 2.1 : 1 and 1800 : 1.
CONCLUSION: In this study referral for justified X-ray procedures in a large hospital with high level medical care offers a significant patient benefit. (c) Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Year:  2009        PMID: 19676012     DOI: 10.1055/s-0028-1109616

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Radiation protection in pediatric radiology.

Authors:  Gerhard Alzen; Gabriele Benz-Bohm
Journal:  Dtsch Arztebl Int       Date:  2011-06-17       Impact factor: 5.594

2.  Effective dose in medicine.

Authors:  C J Martin
Journal:  Ann ICRP       Date:  2020-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.